|
|
||||||||




*
Department of Medicine, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH 44106;
Department of Microbiology, National Institute of Respiratory Diseases, Mexico City, Mexico;
Bronchoscopy Service, National Institute of Respiratory Diseases, Mexico City, Mexico;
§
Department of Pathology, Case Western Reserve University, Cleveland, OH 44106; and
¶
Department of Tuberculosis Immunology, Statens Serum Institute, Copenhagen, Denmark
Protective immunity against Mycobacterium
tuberculosis requires CD4+ lymphocyte-mediated
immune responses and IFN-
activity. As the primary portal of entry
of M. tuberculosis is the lung, pulmonary immune
responses against multiple M. tuberculosis Ags were
compared between both M. tuberculosis-exposed tuberculin
skin test-positive healthy household contacts (HHC) of patients with
active sputum smear and culture-positive tuberculosis and tuberculin
skin test-positive healthy control individuals from the community (CC).
Frequencies of M. tuberculosis Ag-specific
IFN-
-producing cells, IFN-
concentrations in culture
supernatants, and DNA synthesis in bronchoalveolar cells (BAC) and PBMC
were studied in HHC (n = 10) and CC
(n = 15). Using enzyme-linked immunospot assay we
found higher frequencies of IFN-
-producing cells with specificity to
M. tuberculosis-secreted Ag 85 (Ag 85) in BAC from HHC
than in BAC from CC (p < 0.022) and relative to
autologous PBMC, indicating compartmentalization of Ag 85-specific
cells to the lungs. Further, IFN-
-producing cells with specificity
to components A and B of Ag 85 were specifically compartmentalized to
the lungs in HHC (p < 0.05). IFN-
concentrations in culture supernatants of BAC and Ag-specific DNA
synthesis were low and comparable in the two subject groups. Increased
immune responses to Ag 85 at the site of repeated exposure to M.
tuberculosis (the lung) may represent an important component of
protective immunity against M. tuberculosis. Correlates
of protective immunity against M. tuberculosis are
required for assessment of the efficiency of anti-tuberculous
vaccines.
This article has been cited by other articles:
![]() |
C. Jafari, M. Ernst, A. Strassburg, U. Greinert, B. Kalsdorf, D. Kirsten, and C. Lange Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot Eur. Respir. J., February 1, 2008; 31(2): 261 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
R A M Breen, S M Barry, C J Smith, R J Shorten, J P Dilworth, I Cropley, T D McHugh, S H Gillespie, G Janossy, and M C I Lipman Clinical application of a rapid lung-orientated immunoassay in individuals with possible tuberculosis Thorax, January 1, 2008; 63(1): 67 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Ryu, E. J. Kim, S-H. Lee, S. Y. Kim, G. Y. Suh, M. P. Chung, H. Kim, O. J. Kwon, and W-J. Koh Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease Eur. Respir. J., October 1, 2007; 30(4): 736 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lange, C. Jafari, and A. Lalvani Rapid Diagnosis of Smear-negative Tuberculosis by Bronchoalveolar Lavage Enzyme-linked Immunospot Am. J. Respir. Crit. Care Med., August 1, 2007; 176(3): 317 - 317. [Full Text] [PDF] |
||||
![]() |
R. A. M. Breen, A. Dunleavy, and M. C. I. Lipman Rapid Diagnosis of Smear-negative Tuberculosis by Bronchoalveolar Lavage Enzyme-linked Immunospot Am. J. Respir. Crit. Care Med., August 1, 2007; 176(3): 316a - 317. [Full Text] [PDF] |
||||
![]() |
S. B. Sable, D. Goyal, I. Verma, D. Behera, and G. K. Khuller Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins Eur. Respir. J., February 1, 2007; 29(2): 337 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jafari, M. Ernst, B. Kalsdorf, U. Greinert, R. Diel, D. Kirsten, K. Marienfeld, A. Lalvani, and C. Lange Rapid Diagnosis of Smear-negative Tuberculosis by Bronchoalveolar Lavage Enzyme-linked Immunospot Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 1048 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Carranza, E. Juarez, M. Torres, J. J. Ellner, E. Sada, and S. K. Schwander Mycobacterium tuberculosis Growth Control by Lung Macrophages and CD8 Cells from Patient Contacts Am. J. Respir. Crit. Care Med., January 15, 2006; 173(2): 238 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rivas-Santiago, S. K. Schwander, C. Sarabia, G. Diamond, M. E. Klein-Patel, R. Hernandez-Pando, J. J. Ellner, and E. Sada Human {beta}-Defensin 2 Is Expressed and Associated with Mycobacterium tuberculosis during Infection of Human Alveolar Epithelial Cells Infect. Immun., August 1, 2005; 73(8): 4505 - 4511. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Walrath, L. Zukowski, A. Krywiak, and R. F. Silver Resident Th1-Like Effector Memory Cells in Pulmonary Recall Responses to Mycobacterium tuberculosis Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 48 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Sable, R. Kumar, M. Kalra, I. Verma, G. K. Khuller, K. Dobos, and J. T. Belisle Peripheral Blood and Pleural Fluid Mononuclear Cell Responses to Low-Molecular-Mass Secretory Polypeptides of Mycobacterium tuberculosis in Human Models of Immunity to Tuberculosis Infect. Immun., June 1, 2005; 73(6): 3547 - 3558. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Patton, T. C. McGuire, M. T. Hines, R. H. Mealey, and S. A. Hines Rhodococcus equi-Specific Cytotoxic T Lymphocytes in Immune Horses and Development in Asymptomatic Foals Infect. Immun., April 1, 2005; 73(4): 2083 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tully, C. Kortsik, H. Hohn, I. Zehbe, W. E. Hitzler, C. Neukirch, K. Freitag, K. Kayser, and M. J. Maeurer Highly Focused T Cell Responses in Latent Human Pulmonary Mycobacterium tuberculosis Infection J. Immunol., February 15, 2005; 174(4): 2174 - 2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Bonecini-Almeida, J. L. Ho, N. Boechat, R. C. Huard, S. Chitale, H. Doo, J. Geng, L. Rego, L. C. O. Lazzarini, A. L. Kritski, et al. Down-Modulation of Lung Immune Responses by Interleukin-10 and Transforming Growth Factor {beta} (TGF-{beta}) and Analysis of TGF-{beta} Receptors I and II in Active Tuberculosis Infect. Immun., May 1, 2004; 72(5): 2628 - 2634. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Vordermeier, M. A. Chambers, P. J. Cockle, A. O. Whelan, J. Simmons, and R. G. Hewinson Correlation of ESAT-6-Specific Gamma Interferon Production with Pathology in Cattle following Mycobacterium bovis BCG Vaccination against Experimental Bovine Tuberculosis Infect. Immun., June 1, 2002; 70(6): 3026 - 3032. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jepson, A. Fowler, W. Banya, M. Singh, S. Bennett, H. Whittle, and A. V. S. Hill Genetic Regulation of Acquired Immune Responses to Antigens of Mycobacterium tuberculosis: a Study of Twins in West Africa Infect. Immun., June 1, 2001; 69(6): 3989 - 3994. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |